日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responses

靶向 EphA3 的嵌合抗原受体 T 细胞对治疗胶质瘤有效,并能产生治愈性记忆 T 细胞反应

Leesa Lertsumitkul, Melinda Iliopoulos, Stacie S Wang, Sarah J McArthur, Lisa M Ebert, Alexander J Davenport, Raelene Endersby, Jordan R Hansford, Katharine J Drummond, Ryan Cross #, Misty R Jenkins #2

Endogenous H3.3K27M derived peptide restricted to HLA-A∗02:01 is insufficient for immune-targeting in diffuse midline glioma

仅限于 HLA-A∗02:01 的内源性 H3.3K27M 衍生肽不足以在弥漫性中线胶质瘤中进行免疫靶向

Stacie S Wang, Kirti Pandey, Katherine A Watson, Rebecca C Abbott, Nicole A Mifsud, Fiona M Gracey, Sri H Ramarathinam, Ryan S Cross, Anthony W Purcell, Misty R Jenkins

Human EGFRvIII chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma

人类 EGFRvIII 嵌合抗原受体 T 细胞在原位胶质母细胞瘤中表现出良好的安全性和治愈反应

Rebecca C Abbott, Melinda Iliopoulos, Katherine A Watson, Valeria Arcucci, Margareta Go, Hannah E Hughes-Parry, Pete Smith, Melissa J Call, Ryan S Cross, Misty R Jenkins

HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine glioma

HER2 嵌合抗原受体 T 细胞免疫疗法是治疗弥漫性内在性脑桥胶质瘤的有效方法

Stacie S Wang, Alexander J Davenport, Melinda Iliopoulos, Hannah E Hughes-Parry, Katherine A Watson, Valeria Arcucci, Matthias Mulazzani, David D Eisenstat, Jordan R Hansford, Ryan S Cross, Misty R Jenkins

A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma

联合免疫肽组学、蛋白质组学和细胞表面蛋白质组学方法来确定弥漫性内在性脑桥胶质瘤的免疫治疗靶点

Kirti Pandey, Stacie S Wang, Nicole A Mifsud, Pouya Faridi, Alexander J Davenport, Andrew I Webb, Jarrod J Sandow, Rochelle Ayala, Michelle Monje, Ryan S Cross, Sri H Ramarathinam, Misty R Jenkins, Anthony W Purcell

BH3 mimetic drugs cooperate with Temozolomide, JQ1 and inducers of ferroptosis in killing glioblastoma multiforme cells

BH3 模拟药物与替莫唑胺、JQ1 和铁死亡诱导剂协同杀死多形性胶质母细胞瘤细胞

Diane Moujalled, Adam G Southon #, Eiman Saleh #, Kerstin Brinkmann, Francine Ke, Melinda Iliopoulos, Ryan S Cross, Misty R Jenkins, Duong Nhu, Zilu Wang, Melissa X Shi, Ruth M Kluck, Guillaume Lessene, Stephanie Grabow, Ashley I Bush, Andreas Strasser

De novo-designed transmembrane domains tune engineered receptor functions

从头设计的跨膜结构域可调节工程化受体的功能

Assaf Elazar # ,Nicholas J Chandler # ,Ashleigh S Davey # ,Jonathan Y Weinstein ,Julie V Nguyen ,Raphael Trenker ,Ryan S Cross ,Misty R Jenkins ,Melissa J Call ,Matthew E Call ,Sarel J Fleishman

Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastoma

新型高亲和力EGFRvIII特异性嵌合抗原受体T细胞有效消除人类胶质母细胞瘤

Rebecca C Abbott, Daniel J Verdon, Fiona M Gracey, Hannah E Hughes-Parry, Melinda Iliopoulos, Katherine A Watson, Matthias Mulazzani, Kylie Luong, Colleen D'Arcy, Lucy C Sullivan, Ben R Kiefel, Ryan S Cross, Misty R Jenkins

PD-1 blockade enhances elotuzumab efficacy in mouse tumor models

PD-1 阻断可增强小鼠肿瘤模型中的埃罗妥珠单抗疗效

Natalie A Bezman, Amy Jhatakia, Alper Y Kearney, Ty Brender, Mark Maurer, Karla Henning, Misty R Jenkins, Amy J Rogers, Paul J Neeson, Alan J Korman, Michael D Robbins, Robert F Graziano

Repurposed JAK1/JAK2 Inhibitor Reverses Established Autoimmune Insulitis in NOD Mice

重新利用的 JAK1/JAK2 抑制剂可逆转 NOD 小鼠中已建立的自身免疫性胰岛炎

Prerak M Trivedi, Kate L Graham, Nicholas A Scott, Misty R Jenkins, Suktilang Majaw, Robyn M Sutherland, Stacey Fynch, Andrew M Lew, Christopher J Burns, Balasubramanian Krishnamurthy, Thomas C Brodnicki, Stuart I Mannering, Thomas W Kay, Helen E Thomas